153 related articles for article (PubMed ID: 23420532)
1. The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma.
Li W; Tan J; Wang P; Li N; Zhang F
Oncol Lett; 2013 Feb; 5(2):669-674. PubMed ID: 23420532
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
Li W; Tan J; Wang P; Li N; Li C
Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
[TBL] [Abstract][Full Text] [Related]
3. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Li W; Tan J; Wang P; Wu P
Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
[TBL] [Abstract][Full Text] [Related]
4. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
Tan J; Li W; Wang P
Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
[TBL] [Abstract][Full Text] [Related]
7. Theranostic studies of human sodium iodide symporter imaging and therapy using 188Re: a human glioma study in mice.
Guo R; Zhang M; Xi Y; Ma Y; Liang S; Shi S; Miao Y; Li B
PLoS One; 2014; 9(7):e102011. PubMed ID: 25000403
[TBL] [Abstract][Full Text] [Related]
8. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
Chen L; Altmann A; Mier W; Eskerski H; Leotta K; Guo L; Zhu R; Haberkorn U
J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
[TBL] [Abstract][Full Text] [Related]
10. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
[TBL] [Abstract][Full Text] [Related]
12. Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
So Y; Lee YJ; Lee WW; Chung JK
Oncol Rep; 2013 Apr; 29(4):1666-70. PubMed ID: 23404348
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells.
Guo R; Zhang Y; Liang S; Xu H; Zhang M; Li B
Nucl Med Commun; 2010 Oct; 31(10):916-21. PubMed ID: 20683361
[TBL] [Abstract][Full Text] [Related]
14. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
Kim HJ; Jeon YH; Kang JH; Lee YJ; Kim KI; Chung HK; Jeong JM; Lee DS; Lee MC; Chung JK
Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400
[TBL] [Abstract][Full Text] [Related]
15. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
Kim YH; Youn H; Na J; Hong KJ; Kang KW; Lee DS; Chung JK
Theranostics; 2015; 5(1):86-96. PubMed ID: 25553100
[TBL] [Abstract][Full Text] [Related]
16. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
[TBL] [Abstract][Full Text] [Related]
17. Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between
Guo R; Xi Y; Zhang M; Miao Y; Zhang M; Li B
Oncol Lett; 2018 Mar; 15(3):3911-3917. PubMed ID: 29467904
[TBL] [Abstract][Full Text] [Related]
18. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
[TBL] [Abstract][Full Text] [Related]
19. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
Chai W; Yin X; Ren L; Cai M; Long T; Zhou M; Tang Y; Yang N; Hu S
Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
[TBL] [Abstract][Full Text] [Related]
20. [Transfer of sodium iodide symporter gene into glioma cells by recombinant adenovirus and radioiodine therapy for the glioma cells in vitro and in nude mice].
Li W; Tan J; Zheng W; Li N
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):101-4. PubMed ID: 21575476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
